Feb 28, 2023
Featuring a slide presentation and related discussion from Dr Mrinal Gounder, including the following topics:
• Efficacy and tolerability of sorafenib in patients with advanced and refractory desmoid tumors (00:00)
• DESMOPAZ: Results of a Phase II trial of pazopanib versus IV methotrexate/vinblastine for progressive desmoid tumors (1:59)
• Results of the pivotal Phase III DeFi trial evaluating the gamma secretase inhibitor (GSI) nirogacestat for progressing desmoid tumors (3:40)
• Initial results of the Phase II/III RINGSIDE study of the GSI AL102 for the treatment of desmoid tumors (19:47)